Tech Company Financing Transactions
Lila Sciences Funding Round
Lila Sciences, operating out of Cambridge, secured $235 million from Braidwell, Abu Dhabi Investment Authority and Altitude Life Science Ventures.
Transaction Overview
Company Name
Announced On
9/15/2025
Transaction Type
Venture Equity
Amount
$235,000,000
Round
Series A
Investors
Proceeds Purpose
The cash will allow Lila to fund new facilities in Boston, San Francisco and London.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Cambridge, MA Undisclosed
USA
Cambridge, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our mission is to build scientific superintelligence to solve humankind's greatest challenges. New science begins where existing knowledge ends. New medicines and materials are forged beyond the edge of what is known. We predict, we test, we learn, we create. With each idea and experiment, we turn the wheel of science.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Geoffrey von Maltzahn
Browse more venture capital transactions:
Prev: 9/15/2025: ResBiotic venture capital transaction
Next: 9/15/2025: GEOH venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs